For more than 20 yearscovers anti-mites designed to reduce exposure to dust mite allergens in the environment of the allergic patient.
Exposure to dust mite allergens found in bedding is a known contributing factor to respiratory allergies, including allergic rhinitis and allergic asthma. In this context, ProtecSom anti-dust mite covers are used in conjunction with medical supervision to help reduce daily exposure to dust mite allergens, particularly in mattresses, duvets, and pillows.
ProtecSom full covers have been designed to create a physical barrier against dust mite allergens while maintaining a high level of breathability and comfort for everyday use.
The information below compiles a selection of studies, publications, and scientific communications presented at conferences and events specializing in allergology and respiratory health. This research supports the benefits of anti-mites in reducing exposure to dust mite allergens in allergy sufferers.
A follow-up study presented at the World Allergy Organization (WAO) assessed the impact of anti-mites on the quality of life of patients allergic to dust mites.
This study focused on patients equipped with ProtecSom anti-dust mite covers manufactured under a process certified to ISO 13485:2016, an international standard applied to medical devices.
covers anti-mites , the patients monitored reported an average reduction of 62% in their experienced allergy symptoms.
The data collected also highlighted an improvement in respiratory comfort, sleep quality and daily living comfort in patients equipped with ProtecSom covers.
These results highlight the value of ProtecSom anti-dust mite covers in the sustainable reduction of exposure to dust mite allergens from bedding in patients suffering from respiratory allergies.
A multicenter study evaluated the impact of ProtecSom anti-dust mite covers in patients with severe dust mite allergy associated with allergic rhinitis.
For 12 weeks, patients used either a ProtecSom anti-dust mite cover or a placebo cover that was not allergen-proof. Symptoms and quality of life were then assessed using a validated medical questionnaire for allergic rhinoconjunctivitis (miniRQLQ).
The results of this study show that ProtecSom anti-dust mite covers help reduce exposure to dust mite allergens in bedding, with an improvement in allergy symptoms and patient comfort.
This scientific presentation focused on the impact of ISO 13485 certified manufacturing processes on the quality and reliability of anti-mites ProtecSom
ISO 13485:2016 is an international standard applied to medical devices. It governs the design, manufacturing, and quality control processes to ensure the performance, safety, traceability, and medical utility of the product.
The work presented highlights that the reliability of a anti-dust mite cover depends both on the quality of the textile used and on rigorous control of the manufacturing processes.
The assessments carried out focused in particular on:
The results presented show that the application of an ISO 13485 certified process helps to strengthen the reliability and consistency of the performance of anti-mites ProtecSom
Specialists in respiratory health for over 20 years, ProtecSom develops anti-dust mite covers designed to sustainably reduce exposure to dust mite allergens while guaranteeing a high level of daily comfort.
To meet the demands of prolonged daily use, ProtecSom textile technology is based on solid scientific data. It combines barrier effectiveness, breathability, textile flexibility, and good air circulation to preserve the sleeping comfort of allergy sufferers.
The quality of the textile and the mastery of manufacturing processes are essential elements to guarantee reliable anti-dust mite protection.
Unlike some plastic-coated covers or those that rely on chemical acaricide treatments, ProtecSom covers are designed without coatings or biocide treatments. This design combines anti-mites , sleeping comfort, and long-lasting everyday use.
Because respiratory allergies have a real impact on sleep and quality of life, our goal is to develop solutions that are both effective, safe and rigorously evaluated to provide long-term support for allergy patients.